Opioid-sparing Effect of Intravenous Ibuprofen

• Status: Unknown status
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators aimed to evaluate tramadol-sparing effect of intravenous (IV) ibuprofen in patients undergoing percutaneous nephrolithotomy (PCNL).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Muharrem Ucar
• Treatments: Acetaminophen; Ibuprofen

Criteria

Inclusion Criteria:

• Study include 80 patients of American Society of Anesthesiologists (ASA) physical status I-II aged between 18-70 years who scheduled for percutaneous nephrolithotomy operation.

Exclusion Criteria:

• chronic pain,

• psychiatric disease,

• renal dysfunction,

• allergy to nonsteroidal anti-inflammatory drugs,

• history of drug addiction,

• pregnancy,

• inability to use a patient controlled analgesia (PCA) device.